China SXT Pharmaceuticals (SXTC) Loans and Notes Receivables: 2018-2022
- China SXT Pharmaceuticals' Loans and Notes Receivables was N/A to $33,441 in Q3 2022 from the same period last year, while for Sep 2022 it was $33,441, marking a year-over-year change of. This contributed to the annual value of $35,509 for FY2022, which is N/A change from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Loans and Notes Receivables of $33,441 as of Q3 2022, which was down 5.82% from $35,509 recorded in Q1 2022.
- China SXT Pharmaceuticals' 5-year Loans and Notes Receivables high stood at $303,379 for Q1 2018, and its period low was $17,744 during Q1 2020.
- Its 2-year average for Loans and Notes Receivables is $26,161, with a median of $25,696 in 2020.
- Data for China SXT Pharmaceuticals' Loans and Notes Receivables shows a maximum YoY crashed of 78.17% (in 2020) over the last 5 years.
- Quarterly analysis of 4 years shows China SXT Pharmaceuticals' Loans and Notes Receivables stood at $191,784 in 2018, then plummeted by 58.89% to $78,843 in 2019, then slumped by 77.23% to $17,950 in 2020, then reached $33,441 in 2022.
- Its Loans and Notes Receivables was $33,441 in Q3 2022, compared to $35,509 in Q1 2022 and $17,950 in Q3 2020.
